Last reviewed · How we verify

NCT06786845: HOPES

Fibromyalgia and Sleep Disorder Treatment

ENROLLING BY INVITATION NA Last updated 22 January 2025
What this trial tests

NA trial testing Treatment lege artis in Fibromyalgia in 60 participants. Enrolling by invitation.

Timeline
4 September 2024
Primary endpoint
4 September 2025
12 April 2027

Quick facts

Lead sponsorUppsala University
PhaseNA
StatusENROLLING BY INVITATION
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment60
Start date4 September 2024
Primary completion4 September 2025
Estimated completion12 April 2027
Sites1 location across Sweden

Drugs / interventions tested

Conditions studied

Sponsor

Uppsala University

Who can join

Adults 20 to 70, female only, with Fibromyalgia or Sleep Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This longitudinal study will investigate impact of improved sleep quality on chronic pain, fibromyalgia and how the disrupted sleep pattern alters the neuroenvironment.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Fibromyalgia

Currently open trials in the same condition.

Other Uppsala University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06786845.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing